*Department of Dermatology, University of California San Francisco, San Francisco, California;
†Private Practice, San Francisco, California;
‡Department of Dermatology, Saint Louis University, St. Louis, Missouri;
§Department of Dermatology, Howard University College of Medicine, Washington, DC;
║Ophthalmology Division, Medical Associates, Inc., Newport Beach, California;
¶Dermatology Division, SkinCare Physicians, Chestnut Hill, Massachusetts;
#Dermatology Division, Skin Associates of South Florida, Coral Gables, Florida;
**Evidence Scientific Solutions, Philadelphia, Pennsylvania;
††Allergan plc, Irvine, California
Address correspondence and reprint requests to: Richard Glogau, MD, 350 Parnassus Avenue, Suite 400, San Francisco, CA 94117, or e-mail: [email protected]
R. Glogau received payment as an investigator for this clinical trial. D.A. Glaser received payment as an investigator for this clinical trial and previously received grants, consulting fees, travel support, and payment for development of education materials from Kythera Biopharmaceuticals, Inc. V.D. Callender received payment as an investigator for this clinical trial and receives grants and consulting fees from Allergan. S. Yoelin received payment as an investigator for this clinical trial and receives grants, consulting fees, travel support, and payment for development of education materials and lectures (including service on speakers bureaus) from Allergan. J.S. Dover received payment as an investigator for this clinical trial and previously received grants from and was a paid board member for Kythera Biopharmaceuticals, Inc. J.B. Green received payment as an investigator for this clinical trial and receives grants, consulting fees, and payment for lectures (including service on speakers' bureaus) from Allergan. L. Breshears was an employee and stockholder with Evidence Scientific, Inc., at the time the manuscript was written. B. Bowen is an employee of Allergan plc.
